Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03086057 · ClinicalTrials.gov registry record · NA
Optimizing PrEP Uptake & Adherence Among Male Sex Workers (MSW) Using a 2-stage Randomization Design
A NA study of Prevention, sponsored by Brown University.
- Completed
- Registry status
- NA
- Development phase
- 111
- Enrollment target
- 2
- Study locations
NCT03086057: Completed NA study of Prevention, sponsored by Brown University.
NCT03086057 is a NA study of Prevention that has completed, run by Brown University. The registered enrollment target is 111 participants, below the 49,982-participant average among 11 other Prevention trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03086057, a NA study of Prevention, has completed, sponsored by Brown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 111 participants
- Enrollment target
- 2
- Study locations
Study Summary
"PrEPare for Work" is a two-stage randomized controlled pilot trial which utilizes a behavioral intervention to optimize the uptake and adherence of Pre-exposure Prophylaxis (PrEP) in Male Sex Workers (MSW).
Primary Outcome
Number of participants with attendance at initial appointment at PrEP Clinic verified using medical records
Conditions Studied
Interventions
- BEHAVIORAL PrEPare for Work: Strength Based Case Management (Stage 1)
- BEHAVIORAL PrEPare for Work: Adherence Training and Counseling (Stage 2)
Study Locations (2)
Rhode Island
- The Miriam Hospital - Providence
- Brown University School of Public Health - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2019-12-15 |
| Phase | NA |
What the finished NCT03086057 record still lists
NCT03086057 is an interventional study that assigns participants to a tested intervention. The registered 111 participants enrollment target is mid-sized for trials with a published cap, below the 49,982-participant average among 11 other Prevention trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Prevention appearing as the primary indexed condition, and to 2 interventions - of which PrEPare for Work: Strength Based Case Management (Stage 1) is the first listed.
NCT03086057 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT03086057 about?
NCT03086057 is a clinical study titled "Optimizing PrEP Uptake & Adherence Among Male Sex Workers (MSW) Using a 2-stage Randomization Design". "PrEPare for Work" is a two-stage randomized controlled pilot trial which utilizes a behavioral intervention to optimize the uptake and adherence of Pre-exposure Prophylaxis (PrEP) in Male Sex Workers (MSW).
What is the current status of trial NCT03086057?
This trial is currently completed. It is a NA study. The enrollment target is 111 participants. The study started on 2017-05-01. Estimated completion is 2019-12-15.
What conditions does trial NCT03086057 study?
This clinical trial studies the following conditions: Prevention.
What interventions are being tested in trial NCT03086057?
The interventions under investigation include: PrEPare for Work: Strength Based Case Management (Stage 1) (BEHAVIORAL), PrEPare for Work: Adherence Training and Counseling (Stage 2) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03086057?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03086057 being conducted?
This trial has 2 study locations across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prevention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03086057's enrollment target sits among peer trials
111 10th of 11 higher than 2 of 11 other Prevention trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prevention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Randomized Controlled Trial Testing the Effect of the Youth Mindful Awareness Program on Negative Affect (YMAP2).
RECRUITING · NA
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
-
Optimizing PrEP Uptake and Adherence Among Male Sex Workers
RECRUITING · NA
-
Enhancing Oral Cancer Awareness
RECRUITING · NA
-
Virtual Reality Experience for Stress Reduction in Cardiology Patients
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03875716 · 111 participants · NA
Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
- NCT04693468 · 111 participants · Phase 1
Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
- NCT05263050 · 111 participants · Phase 2
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
- NCT05600842 · 111 participants
De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI